Where the blockbuster weight loss drug market stands today — and what’s coming next
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
Fox Business
Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide
Patients will be able to access Eli Lilly's weight loss drug Zepbound at Walmart pharmacies nationwide through its direct-to-consumer program as soon as next month. The partnership between Eli Lilly ...
Hosted on MSN
Massive sales for weight loss drugs spur Eli Lilly’s Q3
As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn acquisition of Metsera, a reserved Eli Lilly posted Q3 results that blew past analyst ...
Obesity Drugs May Drop to as Little as $149 a Month
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
STAT
Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Merck, which has claimed ...
Law
Eli Lilly Sues 2 Texas Companies Over Weight Loss Drug Replicas
Eli Lilly has sued two compounding pharmacies for allegedly producing replicas of its diabetes and weight loss drugs. Eli Lilly has sued companies in 34 states on similar claims, alleging they ...
Morningstar
Eli Lilly's Weight-Loss Drug Meets Primary Endpoint in Diabetes Trials
Eli Lilly said its investigational oral GLP-1 weight-loss drug, orforglipron, met its primary endpoints in two recent phase 3 trials. The medicine company said Wednesday the drug met the primary and ...